Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

"This research highlights the potential for aerobic exercise to serve as a cornerstone in preventive strategies for Alzheimer ...

The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the developing and validating biomarkers for ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Exercise may positively influence the interactions between brain cells in the hippocampus, a brain region involved in ...

Immune cells in the brain called microglia can partially break down large amyloid plaques characteristic of Alzheimer's disease by latching on to them, forming a sort of external stomach and ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

It’s hypothesized that accumulation of cholesterol in the brain cells of Alzheimer's patients directly leads to the formation of tangles of tau and amyloid plaques. Efavirenz may reduce brain ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

A new study published in the Journal of Neurosurgery highlights the potential of focused ultrasound technology in treating Alzheimer’s disease. The clinical trial demonstrated that repetitive opening ...

Innovative Research Combines Ayurvedic Medicine and Chemically Designed Peptides to Combat Amyloid Aggregation in ...